You must be an HFA member to attend this webinar. Become an HFA member.

Learning objectives

After watching this webinar, participants will be able

• to describe the rationale for performing SEQUOIA-HCM;
• describe the basic methodology of SEQUOIA-HCM; and
• report the main findings of SEQUOIA-HCM.

Needs assessment and expected educational outcome

To be made aware of evidence regarding medical treatment of HCM and the contribution of the SEQUOIA-HCM trial in evaluating treatment options, as well as future directions in this field.

Main topic

• Hypertrophic Cardiomyopathy

Treatment

This webinar is designed for cardiologist with an interest in Heart Failure. 

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).